Home › Funds › Euro Pacific Asset Management, LLC › GSK

Euro Pacific Asset Management, LLC position in GSK

GSK PLC ADR F · Health Care

Euro Pacific Asset Management, LLC reported holding 204,907 shares of GSK (GSK PLC ADR F) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.84% of its reported portfolio and ranking #31 among its reported holdings. Euro Pacific Asset Management, LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)204.91K sh
Reported value held$10.32M
Portfolio Weight0.84%
First reportedQ3 2023
Last changeReduce
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Euro Pacific Asset Management, LLC's GSK position evolved

Euro Pacific Asset Management, LLC first disclosed a stake in GSK in Q3 2023 at 232,046 shares (US$8.4M). The position peaked in Q3 2026 at 204,907 shares, worth US$10.3M. Across 13 filings, Euro Pacific Asset Management, LLC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 204,907 shares valued at US$10.3M — a reduction of -1,727 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 232.05K $8.43M New
Q4 2023 234.12K $8.74M Add
Q1 2024 227.79K $9.58M Reduce
Q2 2024 221.22K $8.55M Reduce
Q3 2024 217.89K $8.88M Reduce
Q4 2024 214.16K $7.22M Reduce
Q1 2025 212.97K $8.23M Reduce
Q2 2025 213.26K $8.20M Hold
Q3 2025 212.02K $8.74M Reduce
Q4 2025 210.81K $9.44M Reduce
Q1 2026 208.25K $10.10M Reduce
Q2 2026 206.63K $6.59M Reduce
Q3 2026 204.91K $10.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has Euro Pacific Asset Management, LLC held GSK?

Euro Pacific Asset Management, LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Euro Pacific Asset Management, LLC's current position in GSK?

As of Q3 2026, Euro Pacific Asset Management, LLC holds 204.91K shares of GSK (GSK PLC ADR F), valued at $10.32M, representing 0.84% of its reported portfolio and ranking #31.

Has Euro Pacific Asset Management, LLC been buying or selling GSK?

In the latest 13F filing (Q3 2026), Euro Pacific Asset Management, LLC reduced its position in GSK. The position peaked in Q3 2026 at 204.91K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.